Author name: Yali Friedman

Biotech firms eye rally hungrily With so many firms in dire financial straits, many executives are desperately hoping that this […]

Biotech Stock Report – WOW! The market has gotten ahead of itself by chasing stories, but there is, in fact,

Schering-Plough: Drugmaker, Heal Thyself It has a potential blockbuster and a savvy new CEO. With federal probers and Claritin’s expired

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said

India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets

India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’

This Dutchman Is Flying Maverick biotech firm Genzyme is winning big profits from a contrarian strategy: Think small